All posts tagged drug development

  • Protein.Cannoli.Resized

    Collaboration Between CU Cancer Center and NantBioScience Targets Ral Protein

    Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.

An aging population requires new approaches to prostate cancer care. Image: Flickr/PaulineMak
Cancer Stem Cells
Petri dish, courtesy of Flickr/GavinRice cc license